{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:06:19Z","timestamp":1793239579576,"version":"4.5.0"},"reference-count":61,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2022,4,1]]},"DOI":"10.1001\/jamapsychiatry.2021.4313","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T16:00:50Z","timestamp":1645027250000},"page":"300","source":"Crossref","is-referenced-by-count":120,"title":["Combining Antidepressants vs Antidepressant Monotherapy for Treatment of Patients With Acute Depression"],"prefix":"10.1001","volume":"79","author":[{"given":"Jonathan","family":"Henssler","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University of Cologne Medical School, Cologne, Germany"},{"name":"Charit\u00e9 University Medicine, St Hedwig-Krankenhaus, Clinic for Psychiatry and Psychotherapy, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Alexander","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University of Cologne Medical School, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Schwarzer","sequence":"additional","affiliation":[{"name":"Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Bschor","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University Hospital of Dresden, Dresden, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Baethge","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University of Cologne Medical School, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"3","key":"yoi210086r5","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.17r11470","article-title":"Trajectories of acute antidepressant efficacy: how long to wait for response? a systematic review and meta-analysis of long-term, placebo-controlled acute treatment trials.","volume":"79","author":"Henssler","year":"2018","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"yoi210086r7","first-page":"69","article-title":"Comparing augmentation with non-antidepressants over sticking to antidepressants after treatment failure in depression: a naturalistic study.","volume":"46","author":"K\u00f6hler","year":"2013","journal-title":"Pharmacopsychiatry"},{"issue":"7","key":"yoi210086r8","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1176\/ajp.2006.163.7.1219","article-title":"What happened to lithium? antidepressant augmentation in clinical settings.","volume":"163","author":"Valenstein","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"1","key":"yoi210086r9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1177\/0706743715620411","article-title":"Combining antidepressants in acute treatment of depression: a meta-analysis of 38 studies including 4511 patients.","volume":"61","author":"Henssler","year":"2016","journal-title":"Can J Psychiatry"},{"issue":"1","key":"yoi210086r10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12916-018-1096-5","article-title":"Optimising first- and second-line treatment strategies for untreated major depressive disorder, the SUN?D study: a pragmatic, multi-centre, assessor-blinded randomised controlled trial.","volume":"16","author":"Kato","year":"2018","journal-title":"BMC Med"},{"issue":"1","key":"yoi210086r11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/JCP.0000000000000988","article-title":"Switching to imipramine versus add-on mirtazapine in venlafaxine-resistant major depression: a 10-week randomized open study.","volume":"39","author":"Navarro","year":"2019","journal-title":"J Clin Psychopharmacol"},{"key":"yoi210086r12","doi-asserted-by":"crossref","first-page":"k4218","DOI":"10.1136\/bmj.k4218","article-title":"Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR).","volume":"363","author":"Kessler","year":"2018","journal-title":"BMJ"},{"issue":"7","key":"yoi210086r13","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1017\/S0033291719004069","article-title":"Effectiveness of mirtazapine as add-on to paroxetine v. paroxetine or mirtazapine monotherapy in patients with major depressive disorder with early non-response to paroxetine: a two-phase, multicentre, randomized, double-blind clinical trial.","volume":"51","author":"Xiao","year":"2021","journal-title":"Psychol Med"},{"issue":"5","key":"yoi210086r14","article-title":"Strategies for managing sexual dysfunction induced by antidepressant medication.","author":"Taylor","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"yoi210086r15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"issue":"1","key":"yoi210086r17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3109\/13651501.2012.674533","article-title":"Antidepressant monotherapy compared with combinations of antidepressants in the treatment of resistant depressive patients: a randomized, open-label study.","volume":"17","author":"Bares","year":"2013","journal-title":"Int J Psychiatry Clin Pract"},{"issue":"7","key":"yoi210086r18","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.euroneuro.2009.01.015","article-title":"Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.","volume":"19","author":"Blier","year":"2009","journal-title":"Eur Neuropsychopharmacol"},{"issue":"3","key":"yoi210086r19","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1176\/appi.ajp.2009.09020186","article-title":"Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study.","volume":"167","author":"Blier","year":"2010","journal-title":"Am J Psychiatry"},{"issue":"2","key":"yoi210086r20","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0006-3223(01)01262-8","article-title":"A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine.","volume":"51","author":"Carpenter","year":"2002","journal-title":"Biol Psychiatry"},{"issue":"2","key":"yoi210086r21","first-page":"251","article-title":"Comparison between dothiepin-sertraline combination and dothiepin alone therapy in the treatment of depressive disorder.","volume":"4","author":"Cha","year":"1997","journal-title":"Korean J Biol Psychiatry"},{"issue":"2","key":"yoi210086r22","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1055\/s-2007-979298","article-title":"Morning fluoxetine plus evening mianserin versus morning fluoxetine plus evening placebo in the acute treatment of major depression.","volume":"31","author":"Dam","year":"1998","journal-title":"Pharmacopsychiatry"},{"issue":"5","key":"yoi210086r23","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1097\/JCP.0b013e31822bb1d9","article-title":"A pilot study of the efficacy and safety of paroxetine augmented with risperidone, valproate, buspirone, trazodone, or thyroid hormone in adult Chinese patients with treatment-resistant major depression.","volume":"31","author":"Fang","year":"2011","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"yoi210086r24","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/JCP.0b013e3181e7784f","article-title":"Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.","volume":"30","author":"Fang","year":"2010","journal-title":"J Clin Psychopharmacol"},{"issue":"9","key":"yoi210086r25","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1176\/ajp.151.9.1372","article-title":"Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study.","volume":"151","author":"Fava","year":"1994","journal-title":"Am J Psychiatry"},{"issue":"4","key":"yoi210086r26","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/00004714-200208000-00008","article-title":"Double-blind study of high-dose fluoxetine versus lithium or desipramine augmentation of fluoxetine in partial responders and nonresponders to fluoxetine.","volume":"22","author":"Fava","year":"2002","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"yoi210086r27","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/j.1600-0447.2001.00148.x","article-title":"Benefits from mianserin augmentation of fluoxetine in patients with major depression non-responders to fluoxetine alone.","volume":"103","author":"Ferreri","year":"2001","journal-title":"Acta Psychiatr Scand"},{"issue":"8","key":"yoi210086r28","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.euroneuro.2014.04.004","article-title":"Duloxetine-bupropion combination for treatment-resistant atypical depression: a double-blind, randomized, placebo-controlled trial.","volume":"24","author":"Fornaro","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"issue":"3","key":"yoi210086r29","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1742-7843.2011.00788.x","article-title":"Bupropion as an augmenting agent in patients of depression with partial response.","volume":"110","author":"Gulrez","year":"2012","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"2","key":"yoi210086r30","doi-asserted-by":"publisher","first-page":"403","DOI":"10.4314\/tjpr.v18i2.26","article-title":"Effects of concurrent treatment with amitriptyline hydrochloride tablets and fluoxetine hydrochloride on therapeutic indicator levels in patients with depression.","volume":"18","author":"Jie","year":"2019","journal-title":"Trop J Pharm Res."},{"key":"yoi210086r31","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jpsychires.2017.02.003","article-title":"Non response at week 4 as clinically useful indicator for antidepressant combination in major depressive disorder: a sequential RCT.","volume":"89","author":"Kato","year":"2017","journal-title":"J Psychiatr Res"},{"issue":"4","key":"yoi210086r32","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1055\/s-2007-1014403","article-title":"Combined treatment with imipramine and mianserin: a controlled pilot study.","volume":"25","author":"Lauritzen","year":"1992","journal-title":"Pharmacopsychiatry"},{"issue":"2","key":"yoi210086r33","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.psychres.2009.04.004","article-title":"Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder.","volume":"169","author":"Leuchter","year":"2009","journal-title":"Psychiatry Res"},{"issue":"2","key":"yoi210086r34","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.psychres.2009.06.004","article-title":"Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in major depressive disorder: results of the BRITE-MD study.","volume":"169","author":"Leuchter","year":"2009","journal-title":"Psychiatry Res"},{"issue":"2","key":"yoi210086r35","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00213-002-0999-0","article-title":"Treatment strategies in patients with major depression not responding to first-line sertraline treatment: a randomised study of extended duration of treatment, dose increase or mianserin augmentation.","volume":"161","author":"Licht","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"yoi210086r36","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0165-0327(96)00089-4","article-title":"Efficacy of treatment with trazodone in combination with pindolol or fluoxetine in major depression.","volume":"41","author":"Maes","year":"1996","journal-title":"J Affect Disord"},{"issue":"2","key":"yoi210086r37","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/00004714-199904000-00014","article-title":"Pindolol and mianserin augment the antidepressant activity of fluoxetine in hospitalized major depressed patients, including those with treatment resistance.","volume":"19","author":"Maes","year":"1999","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"yoi210086r38","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4103\/0253-7613.93843","article-title":"Efficacy and safety of add on low-dose mirtazapine in depression.","volume":"44","author":"Matreja","year":"2012","journal-title":"Indian J Pharmacol"},{"issue":"5","key":"yoi210086r39","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3109\/08039489409081375","article-title":"Mianserin added to tricyclic antidepressants in depressed patients not responding to a tricyclic antidepressant alone: a randomized, placebo-controlled, double-blind study.","volume":"48","author":"Medhus","year":"1994","journal-title":"Nord J Psychiatry"},{"issue":"2","key":"yoi210086r40","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1001\/jama.2017.8036","article-title":"Effect of antidepressant switching vs augmentation on remission among patients with major depressive disorder unresponsive to antidepressant treatment: the VAST-D randomized clinical trial.","volume":"318","author":"Mohamed","year":"2017","journal-title":"JAMA"},{"issue":"1","key":"yoi210086r41","first-page":"16","article-title":"A comparative trial of anafranil, pertofran and an anafranil\/pertofran combination.","volume":"5","author":"Murphy","year":"1977","journal-title":"J Int Med Res"},{"issue":"3","key":"yoi210086r42","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.biopsych.2003.08.007","article-title":"Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study.","volume":"55","author":"Nelson","year":"2004","journal-title":"Biol Psychiatry"},{"key":"yoi210086r43","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1192\/bjp.162.3.363","article-title":"The efficacy and tolerability of combined antidepressant treatment in different depressive subgroups.","volume":"162","author":"O\u2019Brien","year":"1993","journal-title":"Br J Psychiatry"},{"issue":"2","key":"yoi210086r44","first-page":"187","article-title":"Combination of citalopram and nortriptyline in the treatment of severe major depression: a double-blind, placebo-controlled trial.","volume":"4","author":"Raisi","year":"2007","journal-title":"Clin Pract"},{"issue":"7","key":"yoi210086r45","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1176\/appi.ajp.2011.10111645","article-title":"Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study.","volume":"168","author":"Rush","year":"2011","journal-title":"Am J Psychiatry"},{"key":"yoi210086r46","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jpsychires.2013.12.001","article-title":"Combination antidepressant therapy for major depressive disorder: speed and probability of remission.","volume":"52","author":"Stewart","year":"2014","journal-title":"J Psychiatr Res"},{"issue":"5","key":"yoi210086r47","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/(ISSN)1099-1077","article-title":"Moclobemide and amitriptyline, alone or in combination, in therapy resistant depression.","volume":"12","author":"Tanghe","year":"1997","journal-title":"Hum Psychopharmacol Clin Exp"},{"issue":"1","key":"yoi210086r48","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1254\/jphs.09013FP","article-title":"Pharmacokinetics and efficacy of fluvoxamine and amitriptyline in depression.","volume":"110","author":"Vezmar","year":"2009","journal-title":"J Pharmacol Sci"},{"issue":"11","key":"yoi210086r49","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1176\/ajp.137.11.1422","article-title":"Combined monoamine oxidase inhibitor-tricyclic antidepressant treatment: a pilot study.","volume":"137","author":"White","year":"1980","journal-title":"Am J Psychiatry"},{"issue":"9","key":"yoi210086r50","first-page":"1312","article-title":"A comparative study of fluoxetine with a little dose of amitriptyline in treating depressive neurosis.","volume":"6","author":"Xu","year":"2002","journal-title":"Chin J Clin Rehabil"},{"issue":"4","key":"yoi210086r51","first-page":"69","article-title":"Comparative study of citalopram combined with amitriptyline for treatment of refractory depression.","volume":"11","author":"Yang","year":"2005","journal-title":"Int Med Health Guid News"},{"issue":"7","key":"yoi210086r52","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.pnpbp.2006.04.018","article-title":"A comparison of the efficacy and tolerability of reboxetine and sertraline versus venlafaxine in major depressive disorder: a randomized, open-labeled clinical trial.","volume":"30","author":"Yazicioglu","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"6201","key":"yoi210086r53","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1136\/bmj.2.6201.1315","article-title":"Controlled trial of trimipramine, monoamine oxidase inhibitors, and combined treatment in depressed outpatients.","volume":"2","author":"Young","year":"1979","journal-title":"Br Med J"},{"issue":"1","key":"yoi210086r54","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.16r10749","article-title":"Switching the antidepressant after nonresponse in adults with major depression: a systematic literature search and meta-analysis.","volume":"79","author":"Bschor","year":"2018","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"yoi210086r55","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.17r11693","article-title":"Dose increase versus unchanged continuation of antidepressants after initial antidepressant treatment failure in patients with major depressive disorder: a systematic review and meta-analysis of randomized, double-blind trials.","volume":"79","author":"Rink","year":"2018","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"yoi210086r56","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1192\/bjp.2018.233","article-title":"Augmentation therapies for treatment-resistant depression: systematic review and meta-analysis.","volume":"214","author":"Strawbridge","year":"2019","journal-title":"Br J Psychiatry"},{"issue":"45","key":"yoi210086r57","first-page":"766","article-title":"Chronic and treatment resistant depression: diagnosis and stepwise therapy.","volume":"111","author":"Bschor","year":"2014","journal-title":"Dtsch Arztebl Int"},{"issue":"2","key":"yoi210086r58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050045","article-title":"Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration.","volume":"5","author":"Kirsch","year":"2008","journal-title":"PLoS Med"},{"issue":"10128","key":"yoi210086r59","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet"},{"key":"yoi210086r60","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.24260","article-title":"Standardized mean differences cause funnel plot distortion in publication bias assessments.","volume":"6","author":"Zwetsloot","year":"2017","journal-title":"Elife"},{"issue":"20","key":"yoi210086r61","first-page":"355","article-title":"Antidepressant withdrawal and rebound phenomena.","volume":"116","author":"Henssler","year":"2019","journal-title":"Dtsch Arztebl Int"},{"key":"yoi210086r1","unstructured":"National Collaborating Centre for Mental Health (UK). Depression: The Treatment and Management of Depression in Adults (Updated Edition). Published online 2010. Accessed October 13, 2020. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK63748\/"},{"key":"yoi210086r2","unstructured":"Gelenberg? AJ, Freeman? MP, Markowitz? JC, . Practice guideline for the treatment of patients with major depressive disorder: third edition. Published October 2010. Accessed January 11, 2022. https:\/\/psychiatryonline.org\/pb\/assets\/raw\/sitewide\/practice_guidelines\/guidelines\/mdd.pdf"},{"key":"yoi210086r3","unstructured":"American Psychological Association. Depression treatments for adults. https:\/\/www.apa.org. Published August 2019. Accessed October 13, 2020. https:\/\/www.apa.org\/depression-guideline\/adults"},{"key":"yoi210086r4","unstructured":"DGPPN, B\u00c4K, KBV, AWMF, Akd\u00c4, BPtK, BApK, DAGSHG, DEGAM, DGPM, DGPs, DGRW, eds; for the Guideline Group Unipolar Depression. S3 Guideline: National Care Guideline (NVL) Unipolar Depression, 2nd edition, Version 1. Published November 2015. Accessed April 12, 2021. http:\/\/www.depression.versorgungsleitlinien.de"},{"key":"yoi210086r6","doi-asserted-by":"crossref","unstructured":"Schneider? F, H\u00e4rter? M, Schorr? S. S3-Leitlinie\/Nationale VersorgungsLeitlinie Unipolare Depression. Published online March 3, 2017. doi:10.1007\/978-3-662-52906-5","DOI":"10.1007\/978-3-662-52906-5"},{"key":"yoi210086r16","doi-asserted-by":"crossref","unstructured":"Higgins? JPT, Thomas? J, Chandler? J, Cumpston? M, Li? T, Page? MJ, Welch? VA, eds. Cochrane Handbook for Systematic Reviews of Interventions, version 6.0. Updated July 2019. Accessed October 21, 2019. http:\/\/www.training.cochrane.org\/handbook","DOI":"10.1002\/9781119536604"}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/2789300\/jamapsychiatry_henssler_2022_oi_210086_1648226527.30122.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T15:02:56Z","timestamp":1649257376000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2789300"}},"subtitle":["A Systematic Review and Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2022,4,1]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2021.4313","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,1]]}}}